Propiedad y actividad de insiders de Adial Pharmaceuticals, Inc. (ADIL): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $5.24 |
| Capitalización | $5M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-07-16 | Coastlands Capital LP | P-Purchase | 1,233 | $3K |
| 2026-07-14 | Coastlands Capital LP | P-Purchase | 2,000 | $5K |
| 2026-07-10 | Coastlands Capital LP | P-Purchase | 1,700 | $5K |
| 2026-07-09 | Coastlands Capital LP | P-Purchase | 10,053 | $28K |
| 2026-06-29 | Coastlands Capital LP | P-Purchase | 25,000 | $65K |
| 2026-06-24 | Coastlands Capital LP | |||
| 2026-06-24 | Coastlands Capital LP | 3,637,818 | $4K | |
| 2026-06-12 | Davidson Matt | A-Award | 232,417 | |
| 2026-06-12 | Davidson Matt | A-Award | 232,417 | $672K |
| 2026-06-11 | Davidson Matt | A-Award | 61,647 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $87993 | $18248 | $3.9M | $6.8M | $4.4M | $6.1M | $4.0M | $2.8M | $3.8M | $5.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $35117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $41758 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $141413 | $27248 | $4.7M | $7.7M | $5.1M | $6.5M | $4.8M | $3.2M | $4.1M | $6.2M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | $304358 | $244421 | $3909 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | $248971 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $7863 | $7298 | $6735 | $6170 | $5606 | $5041 | $4477 | $3913 | $3348 | $2784 |
| Activos Totales | $151526 | $34546 | $4.7M | $7.7M | $5.5M | $7.6M | $5.7M | $4.7M | $5.0M | $6.8M |
| Cuentas por Pagar | $20012 | $342082 | $99671 | $190204 | $648739 | $286192 | $276410 | $103325 | $250130 | $655207 |
| Deuda a Corto | $234255 | $689265 | 0 | 0 | 0 | $49585 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $255019 | $1.0M | $257974 | $539051 | $1.5M | $2.7M | $1.8M | $653076 | $975858 | $1.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $255019 | $1.0M | $257974 | $539051 | $1.5M | $4.1M | $2.5M | $653513 | $975858 | $1.5M |
| Reservas | -$9.9M | -$403992 | -$12.0M | -$20.6M | -$31.5M | -$50.9M | -$63.7M | -$68.8M | -$82.0M | -$90.0M |
| Patrimonio Neto | -$103493 | -$997553 | $4.4M | $7.1M | $4.0M | $3.5M | $3.3M | $4.1M | $4.1M | $5.3M |
| Deuda Total | $234255 | $689265 | 0 | 0 | 0 | $256960 | $207375 | 0 | 0 | 0 |
| Deuda Neta | $146262 | $671017 | -$3.9M | -$6.8M | -$4.4M | -$5.8M | -$3.8M | -$2.8M | -$3.8M | -$5.9M |
| Capital Circulante | -$113606 | -$1.0M | $4.4M | $7.1M | $3.6M | $3.7M | $3.0M | $2.5M | $3.1M | $4.8M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 5.63 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -20.02 |
Rentabilidad
| Rentabilidad sobre capital | -1693.21% |
| Rentabilidad sobre capital invertido | -240.64% |
| Rentabilidad sobre activos | -198.70% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ACXP · APRE · BCDA · BCLI · CDIO · CELZ · HCWB
Explorar sector: Healthcare · Biotechnology
Más secciones de ADIL: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones